The coming wave of patent expiries of first generation commercialized biotherapeutical
drugs has seen the global market open its doors to close copies of these products. These …

Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …

Background In the ongoing pandemic situation of COVID-19, serological tests can
complement the molecular diagnostic methods, and can be one of the important tools of sero …

Abstract Background and Objective Biosimilars represent an opportunity to realise savings
against the costs of innovative medicines. Despite efforts made by stakeholders, there are …

Abstract In South Africa, diabetes is a serious problem where 1 in 9 adults has diabetes,
making it the country with the highest diabetes prevalence on the African continent. Even …

Для повышения доступности такого лечения необходимо расширять
фармацевтический рынок за счет производства неоригинальных препаратов после …

Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …